Catalyst Wire Dossier Catalyst Wire Dossier

ponatinib hydrochloride

ponatinib
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ponatinib hydrochloride, covering 2019-08-06 to 2019-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions [Phase 2]

See pricing